Chemed Corp Stock Price, News & Analysis

Chemed Corporation (NYSE: CHE) reported its first-quarter financial results for 2023, showing a 5.6% increase in revenue to $560 million. GAAP diluted EPS was $3.58, while adjusted diluted EPS slightly rose by 0.6% to $4.82. The VITAS segment generated $310 million in net patient revenue, a 3.8% increase, despite a 10.5% decline in net income and adjusted EBITDA, largely due to Medicare sequestration cuts. Roto-Rooter saw revenue growth of 7.9% to $250 million and a 9.3% increase in net income. Chemed maintained a strong cash position of $58.1 million and reduced its term loan to $21.3 million. Management plans to update 2023 earnings guidance in June.

Chemed Corporation (NYSE: CHE) will announce its financial results for Q1 2023 on April 26, 2023, after market close. A conference call is scheduled for April 27, 2023, at 10 a.m. ET to discuss the results and provide business updates. Interested parties can join through the investor relations section of Chemed’s website or via teleconference. A replay of the call will be available two hours post-conclusion. Chemed operates VITAS Healthcare, the largest provider of hospice care in the U.S., and Roto-Rooter, a leading plumbing and drain cleaning service provider.

Chemed Corporation (NYSE:CHE) announced a virtual presentation at the Oppenheimer 33rd Annual Healthcare Conference on March 14, 2023, at 1:20 p.m. (ET). The presentation will be streamed live and can be accessed on the company's website, www.chemed.com. Following the live event, a replay will be available within 24 hours and accessible for 90 days.

Chemed, headquartered in Cincinnati, Ohio, operates two subsidiaries: VITAS Healthcare, the largest end-of-life hospice provider, and Roto-Rooter, a leading plumbing service company. The announcement highlights Chemed's commitment to transparency and investor relations.

Chemed Corporation (NYSE: CHE) released its fourth-quarter results for 2022, reporting a revenue increase of 1.0% to $547 million. The company’s GAAP diluted EPS stood at $4.13, while adjusted diluted EPS rose 2.7% to $5.39. VITAS Healthcare segment revenue dropped by 2.5% to $308 million, with declines in patient admissions and average daily census. In contrast, Roto-Rooter’s revenue increased by 6.1% to $239 million, driven by a rise in both residential and commercial services. For 2023, VITAS anticipates revenue growth of 6.0% to 7.0%, while Roto-Rooter is expected to grow by 5.0% to 5.5%. The company also repurchased 25,000 shares for $13 million.

Chemed Corporation (NYSE:CHE) has declared a quarterly cash dividend of 38-cents per share, to be paid on March 17, 2023, to shareholders on record as of February 27, 2023. This dividend matches the amount paid in December 2022 and marks the company's 207^th consecutive quarterly dividend in its 50 years as a public entity. Chemed Corporation operates two subsidiaries: VITAS Healthcare, the largest provider of hospice care, and Roto-Rooter, a leading plumbing services company.